Sort
23,748 grants matching “melanoma”
Project 3: Modeling and overcoming resistance to melanoma immunotherapy
$507,562Antoni Ribas · University Of California Los Angeles · P01 · FY2023 · CA
BIOLOGY OF NONMELANOMA SKIN CANCER GROWTH &PROGRESSION
$507,388University Of Texas Md Anderson Can Ctr · P01 · FY2002 · CA
DEVELOPMENT OF BIOMARKERS OF MINIMAL RESIDUAL DISEASE IN STAGE II MELANOMA USING DROPLET DIGITAL PCR-BASED ASSAYS TO DETECT CELL-FREE, METHYLATED DNAS IN PLASMA
$507,253New York University · · FY2021 · Defense Health Agency
Identifying modifiable factors that reduce the burden of late stage melanoma in Hispanics
$507,130Myles G Cockburn · University Of Southern California · R01 · FY2023 · CA
(PQ8) Patient- and tumor-specific biomarkers and mechanisms that predict irAEs resulting from checkpoint inhibition
$507,066Justin M Balko · Vanderbilt University Medical Center · R01 · FY2022 · CA
An Internet-Based Behavioral Intervention for Individuals Diagnosed with Melanoma
$507,030Elliot J Coups · Rbhs -Cancer Institute Of New Jersey · R01 · FY2014 · CA
Community Outreach and Engagement
$506,901Carmen E Guerra · University Of Pennsylvania · P30 · FY2024 · CA
Modulation of asparagine bioavailability and stress response signaling to enhance T cell robustness and maximize immunotherapy
$506,843Ruoning Wang · Research Inst Nationwide Children'S Hosp · R01 · FY2021 · CA
PREDICTING EARLY-STAGE MELANOMA AT HIGH RISK OF RECURRENCE THROUGH MULTIOMICS PROFILING
$506,785The University Of Queensland · · FY2025 · Defense Health Agency
Therapeutically harnessing anti-viral resident memory T cells in solid tumors
$506,676Pamela Rosato · Dartmouth College · R01 · FY2023 · CA
Novel cell therapy approaches for molecularly defined subsets of therapy-resistant melanoma
$506,551Christopher Austin Klebanoff · Sloan-Kettering Inst Can Research · R01 · FY2023 · CA
Project 1: Nanotherapies for Vemurafenib Resistant Melanoma
$506,470Leaf Huang · Univ Of North Carolina Chapel Hill · U54 · FY2016 · CA
Glycosylation Mutants of Mice and Animal Cells
$506,443Pamela M Stanley · Albert Einstein College Of Medicine · R01 · FY2007 · CA
Administrative Core
$506,264Raymond E Samuel · Hampton University · U54 · FY2013 · MD
CTLA-4 Inhibition and Autoimmunity in Melanoma
$506,157University Of Southern California · R01 · FY2004 · CA
Efficacy of Web-based Training in Skin Cancer Triage
$506,111Rhode Island Hospital · R01 · FY2005 · CA
The Genetics of Susceptibility to Mouse Plasma Cell Tumors
$506,056Beverly Mock · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Repurposing drugs and finding new therapeutic targets for cutaneous malignancies
$505,981Natasha Hill · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2023 · AR
Mcl-1 in apoptosis and signal transduction: a structure/function approach
$505,956Maurizio Pellecchia · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2014 · CA
Functional Networks for Persister Cell Sensitivities
$505,756Michael T McManus · University Of California, San Francisco · R01 · FY2020 · CA
Functional Networks for Persister Cell Sensitivities
$505,756Michael T McManus · University Of California, San Francisco · R01 · FY2021 · CA
Localized immunotherapy using alum-binding therapeutics
$505,710Darrell J Irvine · Massachusetts Institute Of Technology · R01 · FY2024 · EB
Differential TGF-Beta Signaling in Bone Microenviroment: Impact on Tumor Growth
$505,665Theresa A Guise · Indiana University Indianapolis · U01 · FY2013 · CA
TECHNETIUM AND RHENIUM IN NUCLEAR MEDICINE
$505,476Harvard University (Medical School) · R01 · FY2003 · EB
NCI National Clinical Trials Network â Network Lead Academic Participating Site
$505,438Lawrence E Flaherty · Wayne State University · UG1 · FY2019 · CA